VCAN and chronic obstructive pulmonary disease: The contribution of versican to the total proteoglycan production was significantly higher in central fibroblasts from COPD patients (0.27 ± 0.04) than in central fibroblasts from control subjects (0.12 ± 0.03) (p < 0.05).